 |
||
|
Rosatom and MEPhI set up a bioprinting laboratory Rosatom, PUBLISHED 07.03.2025 On March 5, the National Research Nuclear University MEPhI (MEPhI) held an opening ceremony for the Laboratory for Regenerative Technologies and Tissue Engineering. The Laboratory, set up with the support of Rosatom, will grow biocompatible equivalents of blood vessels using patients' cells. The biofabricator developed by Rosatom scientists will simulate tissue growth at the micro level. The ceremony was attended by Vladimir Shevchenko, Rector of MEPhI, and Dmitry Baidarov, Director of the New Businesses Support Department at Rosatom. Igor Reshetov, cancer surgeon at I.M. Sechenov First Moscow State Medical University, Vladislav Parfenov, Head of the 3D Bioprinting Center at MEPhi, and Alexander Garmash, Director of the Institute for Physics and Engineering in Biomedicine at MEPhI, addressed the guests emphasizing the importance of an interdisciplinary approach and training of future technology professionals. "This is a wonderful time with technologies evolving at an unprecedented rate. Young people often find it difficult to imagine a world without the internet. Therefore, it is imperative for universities to equip students with the skills and knowledge necessary to navigate future technologies that are being developed today. The faster universities update their educational programs the sooner such laboratories will begin to yield results," said Dmitry Baidarov. Topics: Rosatom Other news: Russia and the IAEA hold another round of Interdepartmental consultations in Moscow The parties reaffirmed their commitment to continue contacts on a regular basis. 417 nuclear units are operating in the world, 62 units are under construction Since the beginning of 2024 six new units have been connected to the grid. 38 nuclear power units with a total capacity of 29.3 GW are scheduled to be commissioned by 2042. |
Hero of the day 
The intergovernmental agreement regulates the conditions and main directions of interaction between the parties within the framework of implementation of the 110 MW SMR project with the possibility of further expansion up to 330 MW. INTERVIEW
Rosatom OPINION
CNNC |